| Name | Title | Contact Details |
|---|
Enterin is pioneering the medical community`s understanding of the link between infections, dysfunction of the enteric nervous system (ENS) of the gut, and the early onset and chronic progression of neurodegenerative disease. We are leveraging years of research to become the first company in the world to develop a novel drug that repairs the dysfunctional gut-brain axis in patients with neurodegenerative disease. Our lead compound, ENT-01 (also known as kenterin), displaces membrane-bound alpha- synuclein (αS) aggregates from nerve cells in the ENS and improves neural signaling between the gut and the brain in preclinical models of Parkinson`s disease. In the gut, this results in improved motility. We are now progressing this drug through clinical trials in an attempt to reverse the constipation of Parkinson`s disease. Our long-term mission is to become the world leader in developing pharmaceutical therapies that repair the gut-brain axis.
Kaiser Permanente is an American integrated managed care consortium, based in Oakland, California, United States, founded in 1945 by industrialist Henry J.
Avanti Benefits is a Morrisville, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
PepperPointe Partnerships is a dental service organization (DSO) that provides support with non-clinical tasks to dental practices, allowing practitioners to focus on providing excellent patient care. PepperPointe seeks to redefine what it means to be ...
Subconscious Training Corporation is a Pompano Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.